ISSN 2368-6820
Vol. 54, Issue 2, 2018August 01, 2018 EDT
Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease—characterization and treatment compliance assessment
Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease—characterization and treatment compliance assessment
Cardoso Ana Verónica, Pereira Nuno, Neves Inês, Santos Vanessa, Jesus José Miguel, Melo Natália, Mota Patrícia Caetano, Morais António, Drummond Marta,
Articles in Vol. 54, Issue 2, 2018
Vol. 54, Issue 2, 2018
- Patterns of bronchial challenge testing in CanadaThériault RémiRaz Amir
- Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease—characterization and treatment compliance assessmentCardoso Ana VerónicaPereira NunoNeves InêsSantos VanessaJesus José MiguelMelo NatáliaMota Patrícia CaetanoMorais AntónioDrummond Marta
- Medical Air: What you don’t know won’t hurt you, but what about your patients?Edwards PaulTherriault Patricia-Ann
- “Tea” time? Cannabis legalization in CanadaJustin Sorge
- Posters from the Canadian Society of Respiratory Therapists Annual Education ConferenceCanadian Society of Respiratory Therapists
1.
Ana Verónica C, Nuno P, Inês N, et al. Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease—characterization and treatment compliance assessment. Canadian Journal of Respiratory Therapy. 2018;54(2). doi:10.29390/cjrt-2018-005